Discontinued — last reported Q1 '18
Archer Daniels Midland Allowance for Doubtful Accounts Receivable (Current) increased by 1.3% to $162.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.5%, from $158.00M to $162.00M. Over 2 years (FY 2023 to FY 2025), Allowance for Doubtful Accounts Receivable (Current) shows a downward trend with a -13.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
A significant increase relative to receivables may signal deteriorating customer credit quality or economic headwinds in specific markets.
This is a contra-asset account representing the estimated amount of accounts receivable that the company expects will no...
Standard across all industries; peers in the medical device sector typically maintain low levels unless operating in high-risk emerging markets.
allowance_for_doubtful_accounts_receivable_current| Q4 '23 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $215.00M | $194.00M | $171.00M | $167.00M | $158.00M | $153.00M | $150.00M | $160.00M | $162.00M |
| QoQ Change | — | -9.8% | -11.9% | -2.3% | -5.4% | -3.2% | -2.0% | +6.7% | +1.3% |
| YoY Change | — | — | — | -22.3% | — | -21.1% | -12.3% | -4.2% | +2.5% |